Bluebird bio Other Liabilities

Bluebird bio (BLUE) currently reports a other liabilities of $0 as of March 2025. In the prior-year period, the figure was $0. Use the charts on this page to explore Bluebird bio's other liabilities history and peer comparisons.

Bluebird bio's other liabilities changed from $0 to $0 (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bluebird bio reported $0 in other liabilities as of March 2025. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bluebird bio, and consider following BLUE for alerts when major investors trade the stock.

Bluebird bio is classified in the Healthcare sector. On other liabilities, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BLUE with unrelated industries.